Envoy Medical, Inc.
COCH
$1.42
$0.042.90%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -51.00% | 37.05% | -28.46% | -431.59% | 111.11% |
| Total Depreciation and Amortization | 16.67% | 23.53% | -29.17% | 65.52% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 238.41% | -189.04% | 1,914.94% | 98.26% | -156.80% |
| Change in Net Operating Assets | 187.34% | 133.89% | 82.48% | -247.82% | 1,077.44% |
| Cash from Operations | 42.81% | 16.05% | 50.07% | -1,165.33% | 127.24% |
| Capital Expenditure | -366.53% | -127.52% | -419.05% | 66.13% | -463.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 200.00% | -- | -- | -- | -- |
| Cash from Investing | 22.15% | -624.77% | -419.05% | 66.13% | -463.64% |
| Total Debt Issued | 200.00% | -50.00% | -- | -100.00% | 0.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | 1,444.04% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.00% | -- |
| Cash from Financing | 144.04% | -62.59% | 850.06% | -105.66% | 424.53% |
| Foreign Exchange rate Adjustments | 0.00% | 0.00% | 50.00% | -100.00% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 183.71% | -540.03% | 105.76% | -175.26% | 1,703.44% |
